Parkinson disease effects in Europe

Parkinson disease is the second most common neurodegenerative disorder. Its annual cost in Europe in 2010 was around 14,000 million Euros, and its effect on the quality of life of patients and their families is incalculable (The Lancet 383; 1107-1109, 2014).

Eye disease gene therapy its usefulness

Some eye desease can be treated nowadays by  cell therapy, although the results have yet to be confirmed (The Lancet, 15 October 2014). However, there is no effective treatment for inherited retinal degeneration at present. Proposed eye disease gene therapy It has now been...

Children with two genetic mothers and a genetic father from a personalist bioethics perspective

Two genetic mothers practice can genetically modify the germline and cause problems in offspring, by being genetically linked three people: two genetic mothers and a father. On 3rd February 2015, the British House of Commons gave the green light to the possibility of using a...
Posted On 08 May 2015
, By